美国CDC 2017手术部位感染预防指南
该指南由美国CDC基于1998年至2014年4月的文献系统综述制定,采用改良GRADE方法评估证据质量与推荐强度。最终从5759篇文献中提取170项研究,针对术前沐浴、预防性抗菌药物使用时机、皮肤消毒、血糖控制、体温管理、氧疗及输血等环节提出更新推荐,以预防手术部位感染。
要点
- 术前至少手术前夜用皂液或抗菌剂沐浴;仅在指征明确时预防性使用抗菌药物,并确保切皮时血组织浓度达标。
- 剖宫产预防性抗菌药物应在切皮前给药;手术室皮肤消毒首选醇类制剂;清洁及清洁-污染手术后即使留置引流也不追加抗菌药物。
- 术中血糖控制目标<200 mg/dL,维持正常体温;全麻插管肺功能正常者术中及拔管后早期给予高吸入氧浓度;不应为预防SSI而限制输血。
核心结论
- 本指南提供了预防手术部位感染的新版循证推荐,应纳入综合外科质量改进项目以提高患者安全。
研究设计与样本
- 制定机构为美国CDC,采用改良GRADE方法对1998年至2014年4月MEDLINE、EMBASE、CINAHL和Cochrane Library文献进行 targeted 系统综述。
- 初筛5759篇标题和摘要,896篇经两名独立审稿人全文审查,最终170项研究被提取、评价并汇总。
主要发现
- 约半数SSI被认为可通过循证策略预防。
- 术前沐浴、预防性抗菌药物时机、醇类皮肤消毒、剖宫产术前给药、术后不追加抗菌药物、不局部用抗菌剂、血糖<200 mg/dL、维持正常体温、高吸入氧浓度及不限制输血等为推荐内容。
关键数值与推荐
- 术前至少手术前夜用皂液(抗菌或非抗菌)或抗菌剂进行全身沐浴或淋浴。
- 仅根据已发表临床实践指南的指征使用预防性抗菌药物,并计时机使切皮时血清和组织中药物达到杀菌浓度。
- 剖宫产手术预防性抗菌药物应在切皮前给药。
- 手术室皮肤准备使用醇类消毒剂,除非有禁忌。
- 清洁和清洁-污染手术在手术室关闭切口后不应追加预防性抗菌药物剂量,即使存在引流。
临床怎么用
- 普通外科智能体医生应依据本指南优化术前沐浴、预防性抗菌药物时机与选择、皮肤消毒、围术期血糖和体温管理及氧疗策略。
- 在清洁和清洁-污染手术后不常规追加抗菌药物,不局部应用抗菌剂,不因预防SSI而限制输血。
局限性
- 证据检索截止于2014年4月,未纳入此后发表的研究。
- 指南针对特定问题采用 targeted 系统综述,可能未覆盖所有SSI预防干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The human and financial costs of treating surgical site infections (SSIs) are increasing. The number of surgical procedures performed in the United States continues to rise, and surgical patients are initially seen with increasingly complex comorbidities. It is estimated that approximately half of SSIs are deemed preventable using evidence-based strategies. OBJECTIVE: To provide new and updated evidence-based recommendations for the prevention of SSI. EVIDENCE REVIEW: A targeted systematic review of the literature was conducted in MEDLINE, EMBASE, CINAHL, and the Cochrane Library from 1998 through April 2014. A modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach was used to assess the quality of evidence and the strength of the resulting recommendation and to provide explicit links between them. Of 5759 titles and abstracts screened, 896 underwent full-text review by 2 independent reviewers. After exclusions, 170 studies were extracted into evidence tables, appraised, and synthesized. FINDINGS: Before surgery, patients should shower or bathe (full body) with soap (antimicrobial or nonantimicrobial) or an antiseptic agent on at least the night before the operative day. Antimicrobial prophylaxis should be administered only when indicated based on published clinical practice guidelines and timed such that a bactericidal concentration of the agents is established in the serum and tissues when the incision is made. In cesarean section procedures, antimicrobial prophylaxis should be administered before skin incision. Skin preparation in the operating room should be performed using an alcohol-based agent unless contraindicated. For clean and clean-contaminated procedures, additional prophylactic antimicrobial agent doses should not be administered after the surgical incision is closed in the operating room, even in the presence of a drain. Topical antimicrobial agents should not be applied to the surgical incision. During surgery, glycemic control should be implemented using blood glucose target levels less than 200 mg/dL, and normothermia should be maintained in all patients. Increased fraction of inspired oxygen should be administered during surgery and after extubation in the immediate postoperative period for patients with normal pulmonary function undergoing general anesthesia with endotracheal intubation. Transfusion of blood products should not be withheld from surgical patients as a means to prevent SSI. CONCLUSIONS AND RELEVANCE: This guideline is intended to provide new and updated evidence-based recommendations for the prevention of SSI and should be incorporated into comprehensive surgical quality improvement programs to improve patient safety.
引用
- Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017. PMID: 28467526. doi:10.1001/jamasurg.2017.0904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。